https://www.avient.com/sites/default/files/2024-11/Color and Additive W_C Product Selection Guide_Web.pdf
LOOK TO US FOR SUPPORT WITH:
Testing and Validation
Fully accredited, in-house testing capabilities to generate data for insight into
material behavior, environmental effects, and more
Regulatory Coordination
Dedicated product stewardship team assisting with new product approvals
to reduce regulatory overhead and minimize risk
Application Development Technical Service
Technical experts specifically trained to work directly with your team in solving
definitive application challenges
Field Technical Service
Onsite support for tool design, startup, and production optimization to gain
manufacturing efficiencies and resolve technical issues
Color and Additive Design Services
Trend and color insights, and product development assistance to optimize design
and gain speed to market
Sustainability
Innovative materials and solutions to help you meet your sustainability goals
Copyright © 2024, Avient Corporation.
https://www.avient.com/sites/default/files/2023-11/AVNT November IR Presentation.pdf
Avient 2011, 2018 and 2021 multiples reflect trailing 12 months EBITDA at December 31.
28
EV / 2023E EBITDA
6.5
8.5
11.0
8.9
12.0 11.9
10.9
9.9
8.2
16.3
13.8
11.9
9.6 9.5 9.5 9.2
7.7
11
21
O
ct
23
PM PP
FM
C C
Avient Historic Multiple
Avient Specialty
Other Specialty /
AP P E N DI X
30
Performance
Additives
16%
Pigments
12%
TiO2
Dyestuffs
2%
Polyethylene
Nylon
Polypropylene
Styrenic Block
Copolymer
Other Raw
Materials
33%
~40% hydrocarbon based
(Grey shaded materials are hydrocarbon based,
includes portion of “Other Raw Materials”)
Non-hydrocarbon
based materials
2022 pro forma results for the acquisition of Avient Protective Materials
RAW MATERIAL BASKET
SEGMENT DATA
U.S. & Canada
40%
37%
18%
2022 PRO FORMA SEGMENT, END MARKET AND GEOGRAPHY
GEOGRAPHY REVENUESEGMENT FINANCIALS
Building and
END MARKET REVENUE
$2,355M $402M
$1,300M $272M
Sales EBITDA
Specialty Engineered Materials
Color Additives and Inks
$592M$3,653M
(1)
9%
32
(1) Total company sales and adjusted EBITDA of $3,653M and $592M, respectively, include intercompany sales eliminations and corporate costs
2022 REVENUE | $2 .4 BILLION
US & Canada
34%
38%
END MARKET REGION
33
34%
21%
Building &
1% Energy
2%
COLOR, ADDITIVES & INKS
2022 PRO FORMA REVENUE | $1 .3 BILLION
US & Canada
52%
35%
34
19%
8%Industrial
16%
9% Defense
Building &
END MARKET REGION
SPECIALTY ENGINEERED MATERIALS
32%
27%
14%
Building &
3%
1% Defense
1%
(18% of sales)
9%
2022 PROFORMA AVIENT REGIONAL SALES
27%
14%
17%
Building &
(37% of sales)Transportation
12%
Building &
US &
Canada
(40% of sales)
7%
56%
23%
7%
Building &
1%
LATAM
(5% of sales)
3%
35
BY END MARKET
Reconciliation of Non-GAAP Financial Measures
(Unaudited)
(Dollars in millions, except for per share data)
Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders
and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special
items, to assess performance and facilitate comparability of results.
https://www.avient.com/sites/default/files/2021-11/avnt-november-investor-meetings.pdf
We are Avient.
6
BETTER TOGETHER: POLYONE AND
CLARIANT COLOR
Key Financial Data (1)
2021E Sales $4.75 billion
2021E EBITDA $580 million
87% of EBITDA from specialty applications
(1) As of October 28, 2021 webcast
Synergies
($ millions)
Three-Year
Estimate
Administrative $ 20
Sourcing 30
Operational 25
Total Synergies $ 75
CLARIANT COST SYNERGIES
• On-track to realize $50 million of expected
synergies in 2021 – up from earlier estimate of $35
million
• Relentless focus on guiding principles for
acquisition integration: safety first, employee
collaboration and exceeding customer expectations
• Future revenue synergies in excess of $50 million
by 2025 are not part of these estimates and
represent additional growth over the long term
8
• Barrier technology
• Functional additives
• Processing aids
• Flame retardants
• Light-weighting
additives
Complementary
Technologies
• Clariant’s approved
formulations and
certified facilities
• Legacy PolyOne’s
leading share in
distribution channels
Healthcare
Solutions
• Clariant’s position
in SE Asia,
Latin America,
Germany & Italy
• Legacy PolyOne’s
position in U.S.,
Canada and China
Regional
Strengths
• Solutions with Avient’s
engineered materials
customers
• Avient’s distribution
channels
Segment
Cross-selling
COMPLEMENTARY TECHNOLOGIES AND
CUSTOMERS DRIVE REVENUE SYNERGIES
Revenue synergy opportunities in excess of $50M by 2025
The complementary aspects of our combined businesses are unquestionable.
APPENDIX
Performance
Additives
Pigments
TiO2
Dyestuffs
4%Polyethylene
Nylon
Polypropylene
Other Raw
Materials
29%
Styrenic Block
Copolymer
~1/3 hydrocarbon based
(Grey shaded materials are hydrocarbon based,
includes portion of “Other Raw Materials”)
Non-hydrocarbon
based materials
36
• Significant raw material price inflation and
tight inventory continued in Q3 2021
o Average cost of hydrocarbon based
materials was up 65% year-over-year and
10% sequentially
o Average cost of non-hydrocarbon based
materials was up 20% year-over-year and
3% sequentially
• Additionally, we continued to experience
other supply chain challenges during Q3
related to raw material spot purchases,
freight constraints and productivity loss
as a result of these shortages
Annual Purchases
RAW MATERIAL AND SUPPLY CHAIN UPDATE
Based on 2020 pro forma purchases, excludes Distribution business
SEGMENT DATA
U.S. & Canada
51%
Latin America
2021 YTD SEGMENT, END MARKET AND GEOGRAPHY
38
GEOGRAPHY REVENUESEGMENT FINANCIALS
23%
19%
Building and
END MARKET REVENUE
(1) Total company sales and EBITDA of $3,617M and $455M, respectively, include intercompany sales eliminations and corporate costs
All charts reflect YTD financials through September 30
$1,820M
$321M
$691M
$127M
$1,206M
$72M
Sales Adjusted EBITDA
Distribution
Specialty Engineered Materials
Color Additives and Inks
$455M$3,617M
34%
21%
7%
Building &
9%
2% Telecommunications
C O L O R , A D D I T I V E S & I N K S
2021 YTD REVENUE | $1 .8 BILL ION
31%
42%
21%
Latin America
END MARKET REGION
39
S P E C I A LT Y E N G I N E E R E D M AT E R I A L S
28%
11%
Building &
7%
2021 YTD REVENUE | $691 MILLION
END MARKET
55%
20%
REGION
40
DI S TR IBU T I ON
26%
22%
20%
Building and
81%
Latin
America
END MARKET REGION
K E Y S U P P L I ER S
2021 YTD REVENUE | $1 .2 BILL ION
41
TOTA L C O M PA N Y R E G I O N A L S A L E S
BY END MARKET
30%
27%
Building &
2% Energy
(16% of sales)
31%
17%
Building &
(25% of sales)
42
19%
17%
Building &
US &
Canada
(51% of sales)
13%
42%
33%
3%
Building &
LATAM
(8% of sales)
Reconciliation of Non-GAAP Financial Measures
(Unaudited)
(Dollars in millions, except for per share data)
September 30, 2021
Reconciliation to Condensed Consolidated Statements of Income
GAAP
Special
Adjusted
Operating income $ 78.7 $ 20.0 $ 98.7
Income from continuing operations before income taxes $ 61.1 $ 19.9 $ 81.0
Income tax expense - GAAP (8.5) — (8.5)
Income tax impact of special items — (4.6) (4.6)
Tax adjustments — (3.6) (3.6)
Net income attributable to noncontrolling interests 0.3 — 0.3
Net income from continuing operations attributable to Avient shareholders $ 52.9 $ 11.7 $ 64.6
Net income / EPS $ 0.57 $ 0.13 $ 0.70
Weighted-average diluted shares 92.2 92.2 92.2
September 30, 2020
Reconciliation to Condensed Consolidated Statements of Income
GAAP
Special
Adjusted
Operating income $ 33.5 $ 40.4 $ 73.9
Income from continuing operations before income taxes $ 5.3 $ 50.0 $ 55.3
Income tax expense - GAAP (2.7) — (2.7)
Income tax impact of special items — (12.7) (12.7)
Tax adjustments — 3.0 3.0
Net income attributable to noncontrolling interests (0.9) — (0.9)
Net income from continuing operations attributable to Avient shareholders $ 1.7 $ 40.3 $ 42.0
Net income / EPS $ 0.02 $ 0.44 $ 0.46
Weighted-average diluted shares 91.9 91.9 91.9
Three Months Ended
Three
Months
Nine
Months
Year Ended
December 31,
Reconciliation to Pro Forma
Adjusted EBITDA 2021 2020
June 30,
2021
September
30, 2021 2020 2019 2018
Net income from continuing
operations – GAAP $ 52.6 $ 2.6 $ 69.4 $ 201.7 $ 133.8 $ 75.7 $ 87.4
Income tax expense 8.5 2.7 20.4 51.8 5.2 33.7 14.4
Interest expense 19.0 29.7 19.5 57.8 74.6 59.5 62.8
Debt extinguishment cost — — — — — — 1.1
Depreciation and amortization from
continuing operations 36.8 36.5 33.8 107.7 115.0 78.1 72.6
EBITDA $ 116.9 71.5 $ 143.1 $ 419.0 $ 328.6 $ 247.0 $ 238.3
Special items, before tax 19.9 50.0 14.2 36.5 66.2 61.7 59.5
Interest expense included in special
items — (9.6) — — (10.1) — —
Depreciation and amortization
included in special items (0.9) (1.3) 1.4 (0.1) (3.2) — (3.0)
Adjusted EBITDA $ 135.9 $ 110.6 $ 158.7 $ 455.4 $ 381.6 $ 308.7 $ 294.8
Clariant MB pro forma adjustments(1) — — — — 75.1 133.2 141.5
Pro forma adjusted EBITDA $ 135.9 $ 110.6 $ 158.7 $ 455.4 $ 456.7 $ 441.9 $ 436.3
(1) Pro forma adjustments for the periods prior to the acquisition date (July 1, 2020) and to give effects to the financing for the acquisition
Reconciliation of EBITDA by Segment
Nine Months
December 31,
2021 2020 2021 2020 2019 2018
Sales:
Color, Additives and Inks $ 586.6 $ 493.8 $ 1,820.3 $ 1,502.9 $ 1,003.8 $ 1,046.5
Specialty Engineered Materials 233.6 174.1 690.7 708.8 745.7 645.8
Distribution 438.8 276.9 1,205.9 1,110.3 1,192.2 1,265.4
Corporate and eliminations (39.2) (20.3) (99.6) (79.9) (79.0) (76.7)
Sales $ 1,219.8 $ 924.5 $ 3,617.3 $ 3,242.1 $ 2,862.7 $ 2,881.0
Operating income:
Color, Additives and Inks $ 66.8 $ 50.5 $ 241.9 $ 180.8 $ 147.4 $ 158.5
Specialty Engineered Materials 31.7 24.7 103.2 94.4 83.7 72.3
Distribution 23.8 17.5 71.5 69.5 75.4 71.5
Corporate and eliminations (43.6) (59.2) (109.4) (155.4) (149.7) (123.7)
Operating income $ 78.7 $ 33.5 $ 307.2 $ 189.3 $ 156.8 $ 178.6
Items below OI in Corporate:
Other income, net $ 1.4 $ 1.5 $ 4.1 $ 24.3 $ 12.1 $ (12.9)
Depreciation & amortization:
Color, Additives and Inks $ 26.6 $ 26.3 $ 79.2 $ 75.1 $ 42.7 $ 44.3
Specialty Engineered Materials 7.9 7.5 23.8 30.0 29.5 23.2
Distribution 0.2 0.2 0.6 0.7 0.5 0.7
Corporate and eliminations 2.1 2.5 4.1 9.2 5.4 4.4
Depreciation & Amortization $ 36.8 $ 36.5 $ 107.7 $ 115.0 $ 78.1 $ 72.6
EBITDA:
Color, Additives and Inks $ 93.4 $ 76.8 $ 321.1 $ 255.9 $ 190.1 $ 202.8
Specialty Engineered Materials 39.6 32.2 127.0 124.4 113.2 95.5
Distribution 24.0 17.7 72.1 70.2 75.9 72.2
Corporate and eliminations (41.5) (56.7) (105.3) (146.2) (144.3) (119.3)
EBITDA $ 116.9 $ 71.5 $ 419.0 $ 328.6 $ 247.0 $ 238.3
EBITDA as a % of Sales:
Color, Additives and Inks 15.9 % 15.6 % 17.6 % 17.0 % 18.9 % 19.4 %
Specialty Engineered Materials 17.0 % 18.5 % 18.4 % 17.6 % 15.2 % 14.8 %
Distribution 5.5 % 6.4 % 6.0 % 6.3 % 6.4 % 5.7 %
Reconciliation of Pro Forma EBITDA - Color, Additives and Inks
Year Ended
December 31,
2020 2019 2018
Sales:
Color, Additives and Inks $ 1,502.9 $ 1,003.8 $ 1,046.5
Clariant MB pro forma
adjustments(1) 540.4 1,118.6 1,209.8
Pro forma sales $ 2,043.3 $ 2,122.4 $ 2,256.3
Operating income:
Color, Additives and Inks $ 180.8 $ 147.4 $ 158.5
Clariant MB pro forma
adjustments(1) 45.0 72.9 80.3
Pro forma operating income $ 225.8 $ 220.3 $ 238.8
Depreciation & amortization:
Color, Additives and Inks $ 75.1 $ 42.7 $ 44.3
Clariant MB pro forma adjustments(1) 30.1 60.3 61.2
Pro forma depreciation & amortization $ 105.2 $ 103.0 $ 105.5
EBITDA
Color, Additives and Inks $ 255.9 $ 190.1 $ 202.8
Clariant MB pro forma
adjustments(1) 75.1 133.2 141.5
Pro forma EBITDA $ 331.0 $ 323.3 $ 344.3
Pro forma EBITDA as a % of Sales 16.2 % 15.2 % 15.3 %
December 31, 2020
Reconciliation of Pro Forma Adjusted
Earnings per Share Avient
Special
Adjusted
Clariant MB
Pro Forma
Adjustments(1)
Pro Forma
Adjusted
Sales $ 3,242.1 $ — $ 3,242.1 $ 540.4 $ 3,782.5
Operating income $ 189.3 $ 73.7 $ 263.0 $ 45.0 $ 308.0
Interest expense, net (74.6) 10.1 (64.5) (18.1) (82.6)
Other income, net 24.3 (17.6) 6.7 — 6.7
Income taxes (5.2) (41.4) (46.6) (6.2) (52.8)
Net income attributable to noncontrolling
interests (1.8) — (1.8) — (1.8)
Net income from continuing operations
attributable to Avient shareholders $ 132.0 $ 24.8 $ 156.8 $ 20.7 $ 177.5
Weighted average diluted shares 90.6
Impact to diluted shares from January 2020 equity offering 1.5
Pro forma weighted average diluted shares 92.1
Pro forma adjusted EPS $ 1.93
December 31, 2019
Reconciliation of Pro Forma Adjusted
Earnings per Share Avient
Special
Adjusted
Clariant MB
Pro Forma
Adjustments(1)
Pro Forma
Adjusted
Sales $ 2,862.7 $ — $ 2,862.7 $ 1,118.6 $ 3,981.3
Operating income $ 156.8 $ 71.7 $ 228.5 $ 72.9 $ 301.4
Interest expense, net (59.5) — (59.5) (33.4) (92.9)
Other income, net 12.1 (10.0) 2.1 — 2.1
Income taxes (33.7) (5.9) (39.6) (9.1) (48.7)
Net income attributable to noncontrolling
interests (0.2) — (0.2) — (0.2)
Net income from continuing operations
attributable to Avient shareholders $ 75.5 $ 55.8 $ 131.3 $ 30.4 $ 161.7
Weighted average diluted shares 77.7
Impact to diluted shares from January 2020 equity offering 15.3
Pro forma weighted average diluted shares 93.0
Pro forma adjusted EPS $ 1.74
AVNT November Investor Meetings.pdf
AVNT Q3 2021 Earnings Presentation.pdf
Final 10.27 606pm Q3 21 IR Deck Version v1.pdf
https://www.avient.com/sites/default/files/2025-03/380605_AVIENT_2024AR_full_250325.pdf
THIS PAGE IS NOT PART OF AVIENT’S FORM 10-K FILING
THIS PAGE IS NOT PART OF POLYONE’S FORM 10-K FILINGTHIS PAGE IS NOT PART OF POLYONE’S FORM 10-K FILINGTHIS PAGE IS NOT PART OF AVIENT’S FORM 10-K FILING
Reconciliation of Non-GAAP Financial Measures
(Unaudited)
(In millions, except for per share data)
Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and
diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items,
to assess performance and facilitate comparability of results.
https://www.avient.com/sites/default/files/2024-10/Avient_CodeConduct_2024_CZ2.pdf
NÁŠ KODEX
CHOVÁNÍ
VYDÁNO: ŘÍJNA 2024
Úvod:
Zpráva od generálního ředitele 1
Pokyny pro etické chování 3
Osobní hodnoty 3
Vaše povinnosti 4
Další povinnosti vedoucích
pracovníků a manažerů
společnosti Avient 4
Otázky a odpovědi 4
Řešení otázek a hlášení
nedodržování předpisů 5
Horká linka pro etiku 5
Zákaz odvetných opatření 6
Uplatňování kodexu chování 6
Porušení kodexu 6
Diverzita a inkluze 8
Diskriminace nebo obtěžování 8
Vztahy na pracovišti 9
Užívání návykových látek 10
Fyzické bezpečí a násilí na
pracovišti 10
Přesné informace, data
a záznamy 12
Účetní integrita 12
Firemní komunikace 14
Zabezpečení a používání majetku 14
Informations exclusives et
confidentielles ; idées et propriété
intellectuelle 15
Soukromí, osobní údaje a
ochrana údajů 16
Používání internetu a e-mailů 16
Sociální média a sdružování v
sociálních sítích 17
Bezpečnost počítačů, licence na
software a autorská práva 17
Informace a obchodování
zasvěcených osob 18
Politické příspěvky/aktivity a
charitativní příspěvky 19
Vládní vyšetřování a dotazy 19
Integrita při našem
podnikání
Spravedlivé jednání 21
Úplatky a nelegální provize 21
Zástupci a konzultanti 22
Spravedlivá soutěž 22
Dary a pohoštění 23
Střety zájmů 24
Nekalé finanční transakce 25
Mezinárodní obchod 25
Praní špinavých peněz 25
Společenská
odpovědnost firmy
Trvalá udržitelnost 27
Bezpečnost, zdraví a životní
prostředí 28
Bezpečnost výrobků a služeb 29
Respektování lidských práv 29
Společný závazek 29
Zdroje informací a
kontaktní údaje
Naše zásady 30
Interní kontakty 30
Horká linka pro etiku 30
Zpráva od generálního ředitele
Vážený týme společnosti Avient,
naše firemní rozhodnutí mají v dnešním složitém a propojeném světě dalekosáhlé následky.
POCTIVOST NA
INTEGRITA PŘI NAŠEM
SPOLEČENSKÁ
KODEX CHOVÁNÍ | 11
Přesné informace, data a záznamy
Úplné, přesné a spolehlivé záznamy jsou zásadně důležité pro správná
rozhodnutí a efektivní provoz.
KODEX CHOVÁNÍ | 12
POCTIVOST NA
INTEGRITA PŘI NAŠEM
SPOLEČENSKÁ
Některé příklady firemních záznamů:
• Vývoj nových produktů
• Výsledky testů
• Laboratorní zprávy
• Údaje z výzkumů
• Finanční výkazy
• Vyúčtování výdajů
• Faktury
• Hodinovníky
• Záznamy o personálu
• Pracovní plány
• Dopisy, zpravodaje a e-mailové adresy spolupracovníků
• Informace publikované v The Loop
Vlastnické a důvěrné informace zahrnují:
• Pracovní plány a strategie směrování
• Údaje z výzkumů a technická data
• Složení výrobků a technologie zpracování
• Řízení výrobků
• Obchodní tajemství, technologie a „know-how“
• Informace o naší konkurenceschopné pozici
• Nepublikované finanční údaje a plány
• Informace o nákladech na výrobky
• Informace o navrhovaných smlouvách a transakcích
• Informace o zákaznících, dodavatelích, cenách a jiné obchodní
informace
• Počítačový software a systémy vyvinuté pro naši společnost
• Jakékoliv jiné informace, které by mohly být užitečné pro konkurenci
KODEX CHOVÁNÍ | 13
POCTIVOST NA
INTEGRITA PŘI NAŠEM
SPOLEČENSKÁ
Otázka: Moje vedoucí je na dovolené a v době její nepřítomnosti
jsem byla požádána, abych jménem společnosti podepsala
smlouvu.
https://www.avient.com/news/unlocking-sustainability-avient-showcase-solutions-circular-economy-chinaplas-2021
Versaflex™ CE Non-Blooming TPEs overmold onto PC and PC/ABS with a smooth surface, and overcome the challenge of surface blooms for consumer electronics while decreasing cycle times.
https://www.avient.com/news/avient-introduces-gravi-tech-metallization-grades-luxury-packaging
The new Gravi-Tech grades are available in polypropylene (PP), acrylonitrile butadiene styrene (ABS), or nylon 6 (PA6) formulations that have densities similar to traditional metals.
https://www.avient.com/products/thermoplastic-elastomers/dynalloy-thermoplastic-elastomers
Formulated specifically for overmolding onto copolyester, PC, ABS for food contact application
https://www.avient.com/industries/healthcare/drug-delivery-systems
Avient’s portfolio of healthcare colorants includes standard and customized color solutions for a variety of polymers, from polyolefins, PC, PEBA, ABS, and styrenics to high temperature polysulfone resins.
https://www.avient.com/news/avient-features-specialty-healthcare-material-solutions-services-mdm-west-2022
Trilliant™ HC8900 Thermoplastics are chemically resistant polymers that offer improved resistance to harsh chemicals and hospital-grade disinfectants compared to other flame-resistant (FR) polymers such as PC/ABS, PC/PET, and copolyester.